Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19.
Emerg Infect Dis
; 27(10): 2728-2731, 2021 Oct.
Article
in English
| MEDLINE | ID: covidwho-1486746
ABSTRACT
We report in vivo selection of a severe acute respiratory syndrome coronavirus 2 spike mutation (Q493R) conferring simultaneous resistance to bamlanivimab and etesivimab. This mutation was isolated from a patient who had coronavirus disease and was treated with these drugs.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Spike Glycoprotein, Coronavirus
/
COVID-19
Limits:
Humans
Language:
English
Journal:
Emerg Infect Dis
Journal subject:
Communicable Diseases
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS